TY - JOUR T1 - 16 Prognostic value of high-sensitivity cardiac troponin T in patients with ST-segment-elevation myocardial infarction JF - Heart JO - Heart SP - A13 LP - A13 DO - 10.1136/heartjnl-2018-ICS.16 VL - 104 IS - Suppl 7 AU - N Khullar AU - A Ibrahim AU - J Saunders AU - C Ahern AU - K Mannix AU - C Cahill AU - TJ Kiernan Y1 - 2018/10/01 UR - http://heart.bmj.com/content/104/Suppl_7/A13.1.abstract N2 - Background The clinical significance of high-sensitivity cardiac troponin T (hs-cTnT) following acute ST-segment-elevation myocardial infarction (STEMI) has not been well established. The aim of this study was to determine the prognostic value of hs-cTnT in the prediction of one-year mortality and repeat revascularisation in STEMI patients.Methods Single center retrospective observational study of patients presenting with STEMI in 2016. Demographic, angiographic, and peak hs-cTnT data were obtained. The relationship between peak hs-cTnT and all-cause mortality and repeat revascularisation was examined.Results 208 patients were included. Mean age was 63.56 years (±12.56), and 73% were males. 78 (37.5%) patients had inferior STEMI and 76 (36.5%) patients had anterior STEMI. 193 (92.8%) patients received primary percutaneous coronary intervention. Median peak hs-cTnT was 2908 ng/L (IQR: 1095, 5485) (<14 ng/L), measured at a median of 1 day from admission; median creatinine of 75 μmol/L (IQR: 68, 95). 18 (8.7%) patients died, and 35 (16.8%) had repeat revascularisation within one year. No significant relationship between peak hs-cTnT and one-year mortality (p=0.150) (figure 1) or repeat revascularisation (p=0.204) (figure 2) was found.Abstract 16 Figure 1 1 year mortalityAbstract 16 Figure 2 1 year revascularisationConclusion Peak hs-cTnT measurements did not predict all-cause mortality or repeat revascularisation. The significance of performing routine peak hs-cTnT measurements in STEMI patients should be investigated further in larger studies. ER -